184 related articles for article (PubMed ID: 8457037)
1. Immunotherapy with aluminum hydroxide adsorbed insect venom extracts (Alutard SQ): immunologic and clinical results of a prospective study over 3 years.
Wyss M; Scheitlin T; Stadler BM; Wüthrich B
Allergy; 1993 Feb; 48(2):81-6. PubMed ID: 8457037
[TBL] [Abstract][Full Text] [Related]
2. Immunoblot studies in allergic patients to hymenoptera venom before and during immunotherapy.
Pereira Santos MC; Pedro E; Spínola Santos A; Branco Ferreira M; Palma Carlos ML; Palma Carlos AG
Eur Ann Allergy Clin Immunol; 2005 Sep; 37(7):273-8. PubMed ID: 16285233
[TBL] [Abstract][Full Text] [Related]
3. Venom-specific IgG antibodies in bee and wasp allergy: lack of correlation with protection from stings.
Ewan PW; Deighton J; Wilson AB; Lachmann PJ
Clin Exp Allergy; 1993 Aug; 23(8):647-60. PubMed ID: 8221268
[TBL] [Abstract][Full Text] [Related]
4. Insect-sting challenge in 324 subjects with a previous anaphylactic reaction: current criteria for insect-venom hypersensitivity do not predict the occurrence and the severity of anaphylaxis.
van der Linden PW; Hack CE; Struyvenberg A; van der Zwan JK
J Allergy Clin Immunol; 1994 Aug; 94(2 Pt 1):151-9. PubMed ID: 8064067
[TBL] [Abstract][Full Text] [Related]
5. Patients still reacting to a sting challenge while receiving conventional Hymenoptera venom immunotherapy are protected by increased venom doses.
Ruëff F; Wenderoth A; Przybilla B
J Allergy Clin Immunol; 2001 Dec; 108(6):1027-32. PubMed ID: 11742283
[TBL] [Abstract][Full Text] [Related]
6. Maintenance venom immunotherapy administered at 3-month intervals is both safe and efficacious.
Goldberg A; Confino-Cohen R
J Allergy Clin Immunol; 2001 May; 107(5):902-6. PubMed ID: 11344360
[TBL] [Abstract][Full Text] [Related]
7. [Allergy to insect stings. diagnosis and therapy (author's transl)].
Urbanek R
Monatsschr Kinderheilkd (1902); 1980 Jan; 128(1):16-20. PubMed ID: 7360118
[TBL] [Abstract][Full Text] [Related]
8. Safety of specific immunotherapy using a four-hour ultra-rush induction scheme in bee and wasp allergy.
Roll A; Hofbauer G; Ballmer-Weber BK; Schmid-Grendelmeier P
J Investig Allergol Clin Immunol; 2006; 16(2):79-85. PubMed ID: 16689180
[TBL] [Abstract][Full Text] [Related]
9. The safety and efficacy of immunotherapy with aluminum hydroxide-adsorbed venom extract of Vespula spp. An open, retrospective study.
Poli F; Longo G; Parmiani S
Allergol Immunopathol (Madr); 2001; 29(5):191-6. PubMed ID: 11720652
[TBL] [Abstract][Full Text] [Related]
10. [Allergic reactions to insect bites].
Urbanek R
Ther Umsch; 1989 Sep; 46(9):654-62. PubMed ID: 2678576
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy with yellow jacket venom. A comparative study including three different extracts, one adsorbed to aluminium hydroxide and two unmodified.
Mosbech H; Malling HJ; Biering I; Böwadt H; Søborg M; Weeke B; Løwenstein H
Allergy; 1986 Feb; 41(2):95-103. PubMed ID: 3518529
[TBL] [Abstract][Full Text] [Related]
12. Insect allergy. A comparative study including case histories and immunological parameters.
Mosbech H
Allergy; 1984 Oct; 39(7):543-9. PubMed ID: 6496884
[TBL] [Abstract][Full Text] [Related]
13. [Desensitization of allergy to hymenoptera venoms].
Przybilla B; Ruëff F
Wien Med Wochenschr; 1999; 149(14-15):421-8. PubMed ID: 10584286
[TBL] [Abstract][Full Text] [Related]
14. [Antibody response pattern (specific IgE and IgG) of insect sting allergic patients in immunotherapy with venom preparations].
Wüthrich B; Arrendal H; Lanner A
Schweiz Med Wochenschr; 1981 Nov; 111(46):1756-65. PubMed ID: 7313646
[TBL] [Abstract][Full Text] [Related]
15. Sublingual desensitization in patients with wasp venom allergy: preliminary results.
Patriarca G; Nucera E; Roncallo C; Aruanno A; Lombardo C; Decinti M; Pascolini L; Milani M; Buonomo A; Schiavino D
Int J Immunopathol Pharmacol; 2008; 21(3):669-77. PubMed ID: 18831935
[TBL] [Abstract][Full Text] [Related]
16. Changes in IgG and IgE antibody levels to bee venom during immunotherapy.
Ferrante A; Mocatta F; Goh DH
Int Arch Allergy Appl Immunol; 1986; 81(3):284-7. PubMed ID: 3770979
[TBL] [Abstract][Full Text] [Related]
17. [Immunotherapy against hymenoptera venom: report of ten patients].
Guzmán M MA; Salinas L J; Toche P P; Marinovic M MA; Gallardo O AM
Rev Med Chil; 2007 Dec; 135(12):1566-71. PubMed ID: 18357358
[TBL] [Abstract][Full Text] [Related]
18. Adverse reactions to venom immunotherapy.
Ramirez DA; Londono S; Evans R
Ann Allergy; 1981 Dec; 47(6):435-9. PubMed ID: 7325415
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of a 12-week maintenance interval in patients treated with Hymenoptera venom immunotherapy.
Kochuyt AM; Stevens EA
Clin Exp Allergy; 1994 Jan; 24(1):35-41. PubMed ID: 8156444
[TBL] [Abstract][Full Text] [Related]
20. [Accelerated desensitization for hymenoptera venom allergy in 30 hours: efficacy and safety in 150 cases].
van der Brempt X; Ledent C; Mairesse M
Rev Med Brux; 1997 Jun; 18(3):120-4. PubMed ID: 9273600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
